BR112023018766A2 - Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b - Google Patents

Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b

Info

Publication number
BR112023018766A2
BR112023018766A2 BR112023018766A BR112023018766A BR112023018766A2 BR 112023018766 A2 BR112023018766 A2 BR 112023018766A2 BR 112023018766 A BR112023018766 A BR 112023018766A BR 112023018766 A BR112023018766 A BR 112023018766A BR 112023018766 A2 BR112023018766 A2 BR 112023018766A2
Authority
BR
Brazil
Prior art keywords
cyclopental
nr2b
allosteric modulators
pyrrle
negative allosteric
Prior art date
Application number
BR112023018766A
Other languages
English (en)
Inventor
Fan Yang
Yaping WANG Kate
Keith Jendza
Matthew Gardinier Kevin
Patrick Healy Mark
Yue Pan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112023018766A2 publication Critical patent/BR112023018766A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b. a presente invenção refere-se a um composto de fórmula (i), ou um sal farmaceuticamente aceitável do mesmo; um método para a fabricação dos compostos da invenção, e seus usos terapêuticos. a presente invenção também fornece uma combinação de agentes farmacologicamente ativos e uma composição farmacêutica.
BR112023018766A 2021-03-26 2022-03-24 Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b BR112023018766A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163166516P 2021-03-26 2021-03-26
PCT/US2022/021624 WO2022204336A1 (en) 2021-03-26 2022-03-24 Novel cyclopental[c]pyrrol negative allosteric modulators of nr2b

Publications (1)

Publication Number Publication Date
BR112023018766A2 true BR112023018766A2 (pt) 2023-10-24

Family

ID=83396075

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023018766A BR112023018766A2 (pt) 2021-03-26 2022-03-24 Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b

Country Status (16)

Country Link
EP (1) EP4313041A1 (pt)
JP (1) JP2024509325A (pt)
KR (1) KR20230160906A (pt)
CN (1) CN117157072A (pt)
AR (1) AR125594A1 (pt)
AU (1) AU2022244367A1 (pt)
BR (1) BR112023018766A2 (pt)
CA (1) CA3212203A1 (pt)
CO (1) CO2023012711A2 (pt)
CR (1) CR20230458A (pt)
DO (1) DOP2023000205A (pt)
EC (1) ECSP23073082A (pt)
IL (1) IL305601A (pt)
TW (1) TW202304885A (pt)
UY (1) UY39688A (pt)
WO (1) WO2022204336A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358551A (zh) * 2012-07-19 2016-02-24 詹森药业有限公司 Ccr2的八氢环戊并吡咯基拮抗剂
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
CN107849008B (zh) * 2015-10-13 2021-04-09 四川海思科制药有限公司 一种八氢环戊烷并[c]吡咯衍生物及其制备方法和在医药上的用途

Also Published As

Publication number Publication date
ECSP23073082A (es) 2023-10-31
IL305601A (en) 2023-11-01
AU2022244367A1 (en) 2023-09-07
TW202304885A (zh) 2023-02-01
UY39688A (es) 2022-10-31
CO2023012711A2 (es) 2023-10-19
AR125594A1 (es) 2023-08-02
WO2022204336A1 (en) 2022-09-29
EP4313041A1 (en) 2024-02-07
DOP2023000205A (es) 2023-11-15
KR20230160906A (ko) 2023-11-24
JP2024509325A (ja) 2024-02-29
CR20230458A (es) 2023-10-27
CA3212203A1 (en) 2022-09-29
CN117157072A (zh) 2023-12-01

Similar Documents

Publication Publication Date Title
BR112014032734A2 (pt) derivados de pirrolidina e seu uso como moduladores da série de reação de complemento
BR112015029512A8 (pt) derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
AU2014251087B2 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
BRPI1011657A2 (pt) derivados aminopropiônicos substituídos como inibidores de neprilisina
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
BR112015016911A2 (pt) tiadiazol, análogos dos mesmos e métodos de tratamento de condições relacionadas à deficiência de smn
BR112013026257A2 (pt) derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112014027359A2 (pt) moduladores da série de reação complementar e usos dos mesmos
BR112021025764A2 (pt) Derivado de pirimidina que inibe o crescimento de células cancerígenas e uso medicinal do mesmo
BR112013026361A2 (pt) derivados de glicosídeo e usos dos mesmos
CR20190147A (es) DERIVADOS DE CROMANO, ISOCROMANO Y DIHIDROISOBENZOFURANOS COMO MODULADORES ALOSTÉRICOS NEGATIVOS DE mGluR2, COMPOSICIONES Y SU USO
BR112015014292A2 (pt) compostos tricíclicos para inibição do canal de cftr
UY39171A (es) Composición farmacéutica para administración oral que comprende derivado de aminopirimidina o sal farmacéuticamente aceptable, hidrato, o solvato de esta
BR112019007863A2 (pt) derivados de naftiridinona inovadores e seu uso no tratamento de arritmia
EA201992127A1 (ru) ФАРМАКОЛОГИЧЕСКИ АКТИВНЫЕ АЛИЦИКЛИЧЕСКИ ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА
BR112019024804A2 (pt) compostos bicíclicos 5,6-fundidos e composições para o tratamento de doenças parasíticas
BR112023018766A2 (pt) Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b
US20080139545A1 (en) Formulation to treat ear infection
ECSP23017158A (es) Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos
BR112015019307A8 (pt) derivados de ácido butanóico substituído com bisfenila, seus usos, e composição farmacêutica
MX2021014544A (es) Derivados de aminoglucosidos antibacterianos.
BR112022024929A2 (pt) Derivados de aminopirimidinila